APA

Cripe L. D., Gelfanov V. M., Smith E. A., Spigel D. R., Phillips C. A., Gabig T. G., Jung S., Fyffe J., Hartman A. D., Kneebone P., Mercola D., Burgess G. S. & Boswell H. S. (20020618). Role for c-jun N-terminal kinase in treatment-refractory acute myeloid leukemia (AML): signaling to multidrug-efflux and hyperproliferation. : Leukemia.

Chicago

Cripe L D, Gelfanov V M, Smith E A, Spigel D R, Phillips C A, Gabig T G, Jung S-H, Fyffe J, Hartman A D, Kneebone P, Mercola D, Burgess G S and Boswell H S. 20020618. Role for c-jun N-terminal kinase in treatment-refractory acute myeloid leukemia (AML): signaling to multidrug-efflux and hyperproliferation. : Leukemia.

Harvard

Cripe L. D., Gelfanov V. M., Smith E. A., Spigel D. R., Phillips C. A., Gabig T. G., Jung S., Fyffe J., Hartman A. D., Kneebone P., Mercola D., Burgess G. S. and Boswell H. S. (20020618). Role for c-jun N-terminal kinase in treatment-refractory acute myeloid leukemia (AML): signaling to multidrug-efflux and hyperproliferation. : Leukemia.

MLA

Cripe L D, Gelfanov V M, Smith E A, Spigel D R, Phillips C A, Gabig T G, Jung S-H, Fyffe J, Hartman A D, Kneebone P, Mercola D, Burgess G S and Boswell H S. Role for c-jun N-terminal kinase in treatment-refractory acute myeloid leukemia (AML): signaling to multidrug-efflux and hyperproliferation. : Leukemia. 20020618.